News Impact
APUS· last 90 days
APIMEDS PHARMACEUTICALS US I
Backward-looking only. These statistics describe how the price moved after past news. They are not a prediction. Sample sizes are small, market context differs every day, and past performance does not predict future results. See methodology and disclaimer.
Bullish news (sentiment ≥ 0.3)
1articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Neutral news (−0.3 to 0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Bearish news (sentiment ≤ −0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Per-event price reaction · 1 events
- BusinessWire5/5/2026, 6:07:00 PMApimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox ProgramSentiment0.60Relevance100%+24h—+72h—+7d—
Not investment advice. See full disclaimer.